Innate Pharma (IPH) — Free Cash Flow Generation Index
Innate Pharma (IPH) has a Free Cash Flow Generation Index of 0.91x as of June 2024. Free cash flow of €2.75 Million represents 1% of operating cash flow (€3.04 Million). See Innate Pharma (IPH) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Innate Pharma Free Cash Flow Generation Index (2006–2019)
Historical FCF Generation Index trend for Innate Pharma across 4 annual periods. Explore IPH operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Innate Pharma (2006–2019)
Year-by-year Free Cash Flow Generation Index for Innate Pharma. For the full company profile including market capitalisation, see market cap of Innate Pharma.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | -0.87x | €-30.48 Million | €34.92 Million | €65.40 Million | ▼ -190.5% |
| 2015 | 0.96x | €200.51 Million | €207.91 Million | €7.40 Million | ▼ -1.1% |
| 2011 | 0.98x | €12.66 Million | €12.99 Million | €322.00K | ▲ +189.6% |
| 2006 | -1.09x | €-392.00K | €360.00K | €752.00K | — |